iv glutathione for parkinson& 39 The system in Parkinson's disease and its progression Frontiers | Glutathione: Pharmacological aspects

All primary antibody incubations (1:1000 in TBST, overnight at 4 C) were followed by incubation with a secondary HRP-conjugated antibody (1:5000 in TBST, 1 h at room temperature), and the signals were visualized using a chemiluminescent HRP substrate on a chemiluminescence imaging system (CHAMPCHEMI TM Chemiluminescent Imaging and Analysis System)

This innovative hydrogel shows promise as an effective material for treating infected wounds, demonstrating the ability to eliminate both Gram-negative and Gram-positive bacteria without causing toxicity to mammalian skin cells

Adler, L

doi: 10.1016/j.neurobiolaging.2012.11.023 105